Loss of PDPK1 Abrogates Resistance to Gemcitabine in Label-Retaining Pancreatic Cancer Cells

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4690-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC